Rationale: Severe respiratory syncytial virus (RSV) bronchiolitis has been associated with deficient IFN-g production in humans, but the role of this cytokine in determining the outcome of reinfection is unknown. Objectives: To define the role of IFN-g in the development of RSVmediated airway hyperresponsiveness (AHR) and lung histopathology in mice. Methods: Wild-type (WT) and IFN-g knockout mice were infected with RSV in the newborn or weaning stages and reinfected 5 weeks later. Airway responses were assessed on Day 6 after the primary or secondary infection. Measurements and Main Results: Both WT and IFN-g knockout mice developed similar levels of AHR and airway inflammation after primary infection. After reinfection, IFN-g knockout mice, but not WT mice, developed AHR, airway eosinophilia, and mucus hyperproduction. Intranasal administration of IFN-g during primary infection but not during reinfection prevented the development of these altered airway responses on reinfection in IFN-g knockout mice. Adoptive transfer of WT T cells into IFN-g knockout mice before primary infection restored IFN-g production in the lungs and prevented the development of altered airway responses on reinfection. Treatment of mice with IFN-g during primary neonatal infection prevented the enhancement of AHR and the development of airway eosinophilia and mucus hyperproduction on reinfection. Conclusions: IFN-g production during primary RSV infection is critical to the development of protection against AHR and lung histopathology on reinfection. Provision of IFN-g during primary infection in infancy may be a potential therapeutic approach to alter the course of RSV-mediated long-term sequelae.